Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00136383Phase 3Completed
A Phase 3 trial of paroxetine in major depressive disorder (MDD), sponsored by Duke University. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00136383.